DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Troxacitabine is an investigational drug.
There have been 4 clinical trials for Troxacitabine. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2005.
The most common disease conditions in clinical trials are Leukemia, Myeloid, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are SGX Pharmaceuticals, Inc., Shire, and [disabled in preview].
Recent Clinical Trials for Troxacitabine
|Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)||SGX Pharmaceuticals, Inc.||Phase 2|
|Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)||SGX Pharmaceuticals, Inc.||Phase 1/Phase 2|
|Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors||SGX Pharmaceuticals, Inc.||Phase 1/Phase 2|